Page 1450 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Chapter 102
https://kat.cr/user/tahir99/

REFERENCES

1. Selye H. A syndrome produced by diverse nocuous agents. 15. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids:
Nature. 1936;136:32. molecular mechanisms. Trends Pharmacol Sci. 1993;14:
2. Marik PE. Critical illness related corticoseroid insufficiency. 436-441.
Chest. 2009;135(1):181-193. 16. Barnes PJ, Karin M. Nuclear factor-kB-A pivotal transcrip-
3. Yaguchi H, Tsutsumi K, Shimono K, et al. Involvement of high den- tion factor in chronic inflammatory diseases. N Engl J Med.
sity lipoprotein as substrate cholestrol for steroidogenesis by bovine 1997;336:1066-1071.
adrenal fasciculo-reticularis cells. Life Sci. 1998;62:1387-1395. 17. Oelkers W. Adrenal insufficiency. N Engl J Med. 1996;335:
4. Rogerson FM, Fuller PJ. Interdomain interactions in the miner- 1206-1212.
alocorticoid receptor. Mol Cellular Endocrinol. 2003;200:45-55. 18. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill:
5. Edwards CR, Stewart PM, Burt D, et al. Localisation of 11 beta- a new look at an old problem. Chest. 2002;122:1784-1796.
hydroxysteroid dehydrogenase—tissue specific protector of the 19. Collins S, Caron MG, Lefkowitz RJ. Beta-adrenergic receptors
mineralocorticoid receptor. Lancet. 1988;2:986-989. in hamster smooth muscle cells are transcriptionally regulated
6. Funder JW, Pearce PT, Smith R, et al. Mineralocorticoid action: by glucocorticoids. J Biol Chem. 1988;263:9067-9070.
target tissue specificity is enzyme, not receptor, mediated. 20. Sakaue M, Hoffman BB. Glucocorticoids induce transcription
Science. 1988;242:583-585. and expression of the alpha 1B adrenergic receptor gene in
7. Tomlinson JW, Moore J, Cooper MS, et al. Regulation of expres- DTT1 MF-2 smooth muscle cells. J Clin Invest. 1991;88:385-389.
sion of 11beta-hydroxysteroid dehydrogenase type 1 in adipose 21. Limbourg FP, Huang Z, Plumier JC, et al. Rapid nontranscrip-
tissue: tissue-specific induction by cytokines. Endocrinology. tional activation of endothelial nitric oxide synthase mediates
2001;142:1982-1989. increased cerebral blood flow and stroke protection by cortico-
8. Cai TQ, Wong B, Mundt SS, et al. Induction of 11beta- steroids. J Clin Invest. 2002;110:1729-1738.
hydroxysteroid dehydrogenase type 1 but not -2 in human 22. Hafezi-Moghadam A, Simoncini T, Yang Z, et al. Acute car-
aortic smooth muscle cells by inflammatory stimuli. J Steroid diovascular protective effects of corticosteroids are mediated
Biochem Mol Biol. 2001;77:117-122. by non-transcriptional activation of endothelial nitric oxide
9. Oakley RH, Jewell CM, Yudt MR, et al. The dominant neg- synthase. Nat Med. 2002;8:473-479.
ative activity of the human glucocorticoid receptor beta 23. Bobadilla NA, Tapia E, Jimenez F, et al. Dexamethasone increases
isoform. Specificity and mechanisms of action. J Biol Chem. eNOS gene expression and prevents renal vasoconstriction
1999;274:27857-27866. induced by cyclosporin. Am J Physiol. 1999;277:F464-F471.
10. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, et al. Human gluco- 24. Murata T, Hori M, Sakamoto K, et al. Dexamethasone blocks
corticoid receptor beta binds RU-486 and is transcriptionally hypoxia-induced endothelial dysfunction in organ-cultured
active. Mol Cell Biol. 2007;27:2266-2282. pulmonary arteries. Am J Respir Crit Care Med. 2004;170:
11. Lu NZ, Collins JB, Grissom SF, et al. Selective regulation of bone 647-655.
cell apoptosis by translational isoforms of the glucocorticoid 25. Cooper MD, Stewart PM. Corticosteroid insufficiency in acutely
receptor. Mol Cell Biol. 2007;27:7143-7160. ill patients. N Engl J Med. 2003;348:727-734.
12. Duma D, Jewell CM, Cidlowski JA. Multiple glucocorticoid 26. Chrousos GP. The hypothalamic-pituitary-adrenal axis and
receptor isoforms and mechanisms of post-translational modi- immune-mediated inflammation. N Engl J Med. 1995;332:
fication. J Steroid Biochem Mol Biol. 2006;102:11-21. 1351-1362.
13. Galon J, Franchimont D, Hiroi N, et al. Gene profiling reveals 27. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for
unknown enhancing and suppressive actions of glucocorticoids severe sepsis and septic shock: a systematic review and meta-
on immune cells. FASEB J. 2002;16:61-71. analysis. Br Med J. 2004;329:480-489.
14. Auphan N, Didonato JA, Rosette C, et al. Immunosuppression 28. Minneci PC, Deans KJ, Banks SM, et al. Meta-analysis: the effect
by glucocorticoids: inhibition of NF-kappa B activity through of steroids on survival and shock during sepsis depends on the
induction of I kappa B synthesis. Science. 1995;270:286-290. dose. Ann Intern Med. 2004;141:47-56.

Section08-O-Ref.indd 1 12/10/2014 6:08:12 PM